scroll down

Xi’an Xuanyu Pharmaceutical Group’s New Factory and R&D Center Officially Begins Operations


On January 19, 2026, Xuanyu Pharmaceutical Group in Xi’an reached another significant milestone in its development: the group’s brand-new, state-of-the-art production base was fully commissioned, and the group’s R&D center was officially inaugurated. This double celebration marks a leap-forward development for the group in two core areas: capacity upgrading and scientific research innovation.

Since its establishment in 2017, the Group has consistently adhered to a prudent and in-depth development strategy, gradually establishing four major production bases that cover the five key sectors of consumer goods, medical devices, cosmetics, food, and health supplements. The newly commissioned full-production facility significantly enhances the Group’s overall production capacity and lean manufacturing capabilities, providing a more robust guarantee for product quality. Concurrently launched, the R&D center will focus on cutting-edge technology development and product innovation; its operation marks the completion of the Group’s closed-loop, end-to-end industrial chain—from R&D and manufacturing to quality control—thereby substantially strengthening its core competitiveness.

Notably, the addition of leading experts—including Professor Liu Qingshan from the School of Pharmacy at the Central University for Nationalities and Professor Jiang Yunyao, Director of the Center for Pharmaceutical Regulation and Health Technology Assessment at Tsinghua University—has infused the R&D center with world-class academic expertise and innovative thinking, further strengthening the Group’s R&D capabilities.

The completion and commissioning of the new factory and R&D center is a crucial step for Xi’an Xuanyu Pharmaceutical Group to enter a new stage of modernization and professional development, and also a generous gift to commemorate the group’s ninth anniversary.

Looking ahead, the Group will continue to deepen its commitment to the greater health industry, driven by ongoing scientific research and innovation, and strive to give back to society with higher-quality products and services, thereby fully ushering in a new chapter of high-quality development.